↓ Skip to main content

Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth

Overview of attention for article published in Experimental Hematology & Oncology, October 2018
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#47 of 156)
  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
5 Mendeley